| TVRAX | VIGAX | TVRAX / VIGAX | |
| Total Expense Ratio | 1.47 | 0.05 | 2,940% |
| Annual Report Gross Expense Ratio | 1.52 | 0.05 | 3,040% |
| Fund Existence | 14 years | 26 years | - |
| Gain YTD | 10.462 | 7.482 | 140% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 2500 | 3000 | 83% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 201M | 379B | 0% |
| Annual Yield % from dividends | 0.67 | 0.38 | 177% |
| Returns for 1 year | 10.05 | 18.72 | 54% |
| Returns for 3 years | 31.95 | 81.36 | 39% |
| Returns for 5 years | 7.25 | 78.70 | 9% |
| Returns for 10 years | 47.02 | 374.92 | 13% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GTMUX | 25.99 | N/A | N/A |
| Goldman Sachs Small/Mid Cap Growth R6 | |||
| VLCAX | 175.58 | N/A | N/A |
| Vanguard Large Cap Index Admiral | |||
| MASKX | 32.18 | N/A | N/A |
| iShares Russell 2000 Small-Cap Idx Instl | |||
| TRZYX | 24.28 | N/A | N/A |
| T. Rowe Price Latin America Z | |||
| MCYIX | 16.37 | -0.51 | -3.02% |
| NYLI Candriam Emerging Markets Eq Cl I | |||